Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials

ClinicalLIVEUpdated 18 Nov 2026

New Clinical Trials

Clinical trials companies registered in the last 30 days, worldwide, with the sponsor, phase and countries.

Sources: ClinicalTrials.gov · Rebuilt weekly · Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase.

Trials
777
in the 30 days to 2026-11-18
Added in 30 days
777
to 18 Nov 2026
Top country
United States
192 · 25% of the list
Phase covered
8
distinct values
Snapshot · 18 Nov 2026
Explore all 777

Signals

What the register says this week, and why it matters if you sell into it.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
  3. 174 of the listed studies are device, diagnostic or digital-health studies (no drug phase).
  4. A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

Export the full new clinical trials

777 rows as a .csv. Free. Every field, with its source link.

Country
Phase
Study type
777 / 777 trials
PostedSponsorStudyPhaseStatus
26 Oct 2026Xiamen Amoytop Biotech Co., Ltd.ChinaA Clinical Study of Long-Term Administration of Inpegsomatropin Injection in Participants With Idiopathic Short Stature Who Have Completed Phase Ⅲ Clinical TrialsNot applicableRecruiting23 Oct 2026AN2 Therapeutics, IncAustraliaPhase 2 Study of Oral Epetraborole in Adults With Polycythemia VeraPhase 2Not Yet Recruiting23 Oct 2026Ancestral Supplements, LLCUnited StatesA Study to Evaluate the Effects of a Beef Liver Supplement on Energy, Mood, and Mental ClarityNot applicableActive Not Recruiting23 Oct 2026Ascletis Pharma (China) Co., LimitedUnited StatesA Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC36 Tablets for Oral Use in Adult Participants With Obesity or OverweightPhase 1Recruiting23 Oct 2026Ascletis Pharma (China) Co., LimitedUnited StatesA Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Two Formulations of ASC36 Injection in Participants With Obesity or OverweightPhase 1Recruiting23 Oct 2026Axiom BioregistryJordanMENA/Levant Epidemiological, Registry of Immunological & Clinical Traits (MERIT)Not Yet Recruiting23 Oct 2026BioNTech SEA First-in-human Clinical Trial to Test if the Investigational Drug BNT3219 is Safe and Potentially Beneficial for People With Advanced Solid Tumors When Given Alone or Together With Other Investigational DrugsPhase 1Not Yet Recruiting23 Oct 2026CellinCellsSouth KoreaCIC101-02-LT is a Long-term Follow-up Study of Participants Treated With TRTP-101 and Will Evaluate the Long-term Safety and Efficacy of TRTP-101.Recruiting23 Oct 2026CSPC Megalith Biopharmaceutical Co.,Ltd.Immunogenicity and Safety of SYS6052 in the Participants Aged 40 Years and AbovePhase 1, Phase 2Not Yet Recruiting23 Oct 2026DaniscoCanadaA Study of Single and Combination Lipase Dietary Supplements to Increase Fatty Acid Absorption in Generally Health AdultsPhase 1, Phase 2Not Yet Recruiting23 Oct 2026Fisher and Paykel HealthcareNasal High Flow Oxygen in Patients With Lower-Limb IschaemiaNot applicableNot Yet Recruiting23 Oct 2026Galderma R&DChinaA Study to Evaluate the Long-term Safety and Effectiveness of Sculptra™Recruiting23 Oct 2026GuangZhou Cellgenes Biotechnology Co., Ltd.ChinaClinical Trial of CG-BM1 Allogeneic Human Bone Marrow Mesenchymal Stem Cell Injection in the Treatment of Acute Respiratory Distress SyndromePhase 1Completed23 Oct 2026Hansoh BioMedical R&D CompanyA Phase I Study of HS-20093 in Combination With ZG006 With or Without Adebrelimab in Patients With ES-SCLCPhase 1Not Yet Recruiting23 Oct 2026Hikma Pharmaceuticals USA Inc.United StatesPharmacokinetics and Safety of a Single Dose of Epinephrine Nasal Spray in Paediatric Allergy PatientsPhase 2Not Yet Recruiting23 Oct 2026Keymed Biosciences Co.LtdChinaStudy of CM529D1 in Participants With Advanced Solid TumorsPhase 1, Phase 2Not Yet Recruiting23 Oct 2026McNeil ABCanadaA Study of Nicotine Orodispersible Tablet on Craving Relief of Male and Female Smoker VolunteersPhase 2Recruiting23 Oct 2026NutromicsUnited StatesVancomycin Exposure and Biomarker Tracking Using Real-time Monitoring of Interstitial FluidNot Yet Recruiting23 Oct 2026SalivIQ Diagnostics, Inc.United StatesA Multicenter Evaluation of SalivIQ™ Strep A for Detecting Group A Streptococcus From Saliva and Throat Swabs in Patients With Acute PharyngitisRecruiting23 Oct 2026Sichuan Credit Pharmaceutical Co., Ltd.IndiaA Randomized, 52-Week Extension Study to Evaluate the Maintenance of Remission, Relapse Prevention, and Long-Term Safety of CreNeuroS™ in Patients With Major Depressive Disorder Who Achieved Remission Following an 8-Week Parent StudyNot applicableRecruiting23 Oct 2026Sonavex, Inc.United StatesStudy of 3D Ultrasound for Support of Hemodialysis CannulationNot applicableRecruiting23 Oct 2026Sunshine Lake Pharma Co., Ltd.ChinaHEC53856 Tablets for Chemotherapy-induced Anemia in Non-myeloid MalignanciesPhase 2Not Yet Recruiting23 Oct 2026WAKEZ HEALTH TECH ECOSYSTEM SRLRomaniaREM Sleep Disruption and Its Potential Uses in Depression ManagementNot applicableCompleted22 Oct 2026Akita Biosciences, Inc.United StatesFeasibility, Acceptability, and Safety of a Drug-Free Nasal Spray in Frontline Healthcare WorkersNot applicableCompleted22 Oct 2026Aktis Oncology, Inc.United StatesA Study of [225Ac]Ac-AKY-2519 in Patients With B7-H3 Expressing Solid TumorsPhase 1Recruiting22 Oct 2026AMCGMCG Algorithm Optimization Study in Patients With Coronary Artery StenosisNot Yet Recruiting22 Oct 2026AstraZenecaChinaObservational Study of the Real-world Effectiveness and Safety of Selumetinib Treating Adult Patients With Neurofibromatosis Type 1 (NF1) Who Have Symptomatic, Inoperable Plexiform Neurofibroma (PN)Recruiting22 Oct 2026AVEO Pharmaceuticals, Inc.Master Protocol for the Study of Rilogrotug for the Treatment of Weight Loss and Anorexia in Patients With Cancer Cachexia and mCRC or mNSCLCPhase 2, Phase 3Not Yet Recruiting22 Oct 2026Bavarian NordicUnited StatesPhase 1 Trial to Evaluate Safety and Immunogenicity of MVA-BN-EBV in Healthy Young AdultsPhase 1Not Yet Recruiting22 Oct 2026Beijing Keymed Biosciences Co., Ltd.ChinaStudy of CM512 Injection in Patients With Perennial Allergic Rhinitis on Background TherapyPhase 2Not Yet Recruiting22 Oct 2026Beijing Suncadia Pharmaceuticals Co., LtdChinaA Study to Evaluate the Safety, Tolerability and Pharmacokinetics of SHR 3201 Injection in Healthy ParticipantsPhase 1Not Yet Recruiting22 Oct 2026BiogenA Study to Learn About the Effects of Felzartamab on the Kidneys of Adults With Immunoglobulin A Nephropathy (IgAN)Phase 2Not Yet Recruiting22 Oct 2026Bionime CorporationTaiwanRIGHTEST iFree 2 CGM System for Glycemic Control in Adults With Diabetes MellitusNot applicableRecruiting22 Oct 2026Bionime CorporationGermanyEffectiveness and Safety of the RIGHTEST™ CGM System for Blood Glucose Management in Persons With Diabetes MellitusNot applicableCompleted22 Oct 2026Bionime CorporationGermanyRIGHTEST iFree 2 CGM in Pregnant Women With Diabetes StudyNot applicableRecruiting22 Oct 2026ChinaNormChinaB5 Serum 4-week Clinical StudyNot applicableCompleted22 Oct 2026Daiichi SankyoTaiwanA Study of Dato-DXd in Participants With Solid Tumors [TROPION-PanTumor04 (TP04)]Phase 1, Phase 2Recruiting22 Oct 2026Dizal PharmaceuticalsChinaAssessing the Effect of a Proton Pump Inhibitor on the Pharmacokinetics of DZD8586 in Healthy Participants (TAI-SHAN21)Phase 1Recruiting22 Oct 2026Edesa Biotech Inc.Canada, PanamaA Study of EB06 Versus Placebo in Adults With Moderate to Severe Non-segmental VitiligoPhase 2Recruiting22 Oct 2026Efferon JSCRussiaQuality of Life in Patients With Post-Sepsis SyndromeNot Yet Recruiting22 Oct 2026Eli Lilly and CompanyUnited States, ArgentinaA Study to Investigate the Effect of LY4086940 Versus Placebo in Participants With Obesity or Overweight and Without Type 2 DiabetesPhase 2Not Yet Recruiting22 Oct 2026EvolvUnited StatesA Controlled Study to Evaluate the Effects of a Supplement on Weight Loss, Blood Sugar, and Appetite SuppressionNot applicableCompleted22 Oct 2026Fosun Pharmaceutical Industrial Development (Shenzhen) Co., Ltd.ChinaA Phase II Study of FXR0906 in Patients With Severe Hypertriglyceridemia or Hypertriglyceridemia With ASCVD.Phase 2Not Yet Recruiting22 Oct 2026Hoffmann-La RocheA Clinical Study to Evaluate the Effects of Enicepatide Versus Tirzepatide in Participants With Type 2 Diabetes and Inadequate Blood Sugar Control on Oral Glucose-Lowering MedicationsPhase 3Not Yet Recruiting22 Oct 2026Hrain Biotechnology Co., Ltd.Non-Interventional Study of Ranicabtagene Autoleucel Injection for Relapsed/Refractory B-cell Non-Hodgkin LymphomaNot Yet Recruiting22 Oct 2026iBio, Inc.AustraliaA Study to Evaluate a Single Dose of IBIO-610 in Participant With Obesity.Phase 1Not Yet Recruiting22 Oct 2026Immunome, Inc.A Phase 1 Study of IM-1340 in Participants With Advanced CancerPhase 1Not Yet Recruiting22 Oct 2026Janssen Korea, Ltd., KoreaSouth KoreaA Study of Opsynvi in Adults Participants With Pulmonary Arterial Hypertension in KoreaNot Yet Recruiting22 Oct 2026Jiangsu Guiqiong Pharmaceutical Co., Ltd.ChinaA Phase II Clinical Study Evaluating the Efficacy and Safety of SXRN Injection in Patients With Cancer CachexiaPhase 2Not Yet Recruiting22 Oct 2026Lipocosm, LLCUnited StatesA Study to Evaluate the Benefits of Harmonic Vibration LiposuctionActive Not Recruiting

// How AOS uses this

Every row here is a potential account. AOS finds the ones that need what you sell, maps the decision makers and prepares the outreach for your approval.